Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated gram-negative bacterial killing: An effect abrogated within the cystic fibrosis lung

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2418-2431

  Vega Carrascal, Isabel ^a   Bergin, David A ^a   McElvaney, Oliver J ^a   McCarthy, Cormac ^a   Banville, Nessa ^a   Pohl, Kerstin ^a   Hirashima, Mitsuomi ^b   Kuchroo, Vijay K ^c   Reeves, Emer P ^a   McElvaney, Noel G ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b KAGAWA UNIVERSITY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; ECALECTIN; INTERLEUKIN 8; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CLEARANCE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEGRANULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG FIBROSIS; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; UPREGULATION;

CYSTIC FIBROSIS; FEMALE; GALECTINS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MEMBRANE PROTEINS; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

EID: 84896536402     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300711     Document Type: Article

References (82)

1. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951.
2. Riordan, J. R., J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J. L. Chou, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
3. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J. L. Cole, D. Kennedy, N. Hidaka, et al. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
4. Rowntree, R. K., and A. Harris. 2003. The phenotypic consequences of CFTR mutations. Ann. Hum. Genet. 67: 471-485.
5. Welsh, M. J., and A. E. Smith. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73: 1251-1254.
6. Davis, P. B. 2006. Cystic fibrosis since 1938. Am. J. Respir. Crit. Care Med. 173: 475-482.
7. Lipuma, J. J. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23: 299-323.
8. Hayes, E., K. Pohl, N. G. McElvaney, and E. P. Reeves. 2011. The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch. Immunol. Ther. Exp. (Warsz.) 59: 97-112.
9. Brennan, S., D. Cooper, and P. D. Sly. 2001. Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin. Thorax 56: 62-64.
10. Alexis, N. E., M. S. Muhlebach, D. B. Peden, and T. L. Noah. 2006. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J. Cyst. Fibros. 5: 17-25.
11. Koller, D. Y., R. Urbanek, and M. Götz. 1995. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am. J. Respir. Crit. Care Med. 152: 629-633.
12. Taggart, C., R. J. Coakley, P. Greally, G. Canny, S. J. O'Neill, and N. G. McElvaney. 2000. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-Alpha and interleukin-8. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L33-L41.
13. Wang, Y., J. Meng, X. Wang, S. Liu, Q. Shu, L. Gao, Y. Ju, L. Zhang, W. Sun, and C. Ma. 2008. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand. J. Immunol. 67: 63-70.
14. Kuchroo, V. K., V. Dardalhon, S. Xiao, and A. C. Anderson. 2008. New roles for TIM family members in immune regulation. Nat. Rev. Immunol. 8: 577-580.
15. Su, E. W., J. Y. Lin, and L. P. Kane. 2008. TIM-1 and TIM-3 proteins in immune regulation. Cytokine 44: 9-13.
16. Rodriguez-Manzanet, R., R. DeKruyff, V. K. Kuchroo, and D. T. Umetsu. 2009. The costimulatory role of TIM molecules. Immunol. Rev. 229: 259-270.
17. Recalcati, S., P. Invernizzi, P. Arosio, and G. Cairo. 2008. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J. Autoimmun. 30: 84-89.
18. Seki, M., S. Oomizu, K. M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127: 78-88.
19. Rennert, P. D., T. Ichimura, I. D. Sizing, V. Bailly, Z. Li, R. Rennard, P. McCoon, L. Pablo, S. Miklasz, L. Tarilonte, and J. V. Bonventre. 2006. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J. Immunol. 177: 4311-4321.
20. Khademi, M., Z. Illés, A. W. Gielen, M. Marta, N. Takazawa, C. Baecher-Allan, L. Brundin, J. Hannerz, C. Martin, R. A. Harris, et al. 2004. T Cell Ig-And mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluidderived mononuclear cells in multiple sclerosis. J. Immunol. 172: 7169-7176.
21. Sánchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X. X. Zheng, C. A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V. K. Kuchroo, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto-And alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4: 1093-1101.
22. Jayaraman, P., I. Sada-Ovalle, S. Beladi, A. C. Anderson, V. Dardalhon, C. Hotta, V. K. Kuchroo, and S. M. Behar. 2010. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J. Exp. Med. 207: 2343-2354.
23. Sakuishi, K., P. Jayaraman, S. M. Behar, A. C. Anderson, and V. K. Kuchroo. 2011. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 32: 345-349.
24. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252.
25. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541.
26. Rangachari, M., C. Zhu, K. Sakuishi, S. Xiao, J. Karman, A. Chen, M. Angin, A. Wakeham, E. A. Greenfield, R. A. Sobel, et al. 2012. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat. Med. 18: 1394-1400.
27. Hastings, W. D., D. E. Anderson, N. Kassam, K. Koguchi, E. A. Greenfield, S. C. Kent, X. X. Zheng, T. B. Strom, D. A. Hafler, and V. K. Kuchroo. 2009. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39: 2492-2501.
28. Vij, N., S. Mazur, and P. L. Zeitlin. 2009. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: e4664.
29. Hunter, M. J., K. J. Treharne, A. K. Winter, D. M. Cassidy, S. Land, and A. Mehta. 2010. Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling. PLoS ONE 5: e11598.
30. Yang, X., X. Jiang, G. Chen, Y. Xiao, S. Geng, C. Kang, T. Zhou, Y. Li, X. Guo, H. Xiao, et al. 2013. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J. Immunol. 190: 2068-2079.
31. Schorn, C., C. Janko, V. Krenn, Y. Zhao, L. E. Munoz, G. Schett, and M. Herrmann. 2012. Bonding the foe -NETting neutrophils immobilize the proinflammatory monosodium urate crystals. Front Immunol 3: 376.
32. Reeves, E. P., H. Lu, H. L. Jacobs, C. G. Messina, S. Bolsover, G. Gabella, E. O. Potma, A. Warley, J. Roes, and A. W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297.
33. Bergin, D. A., E. P. Reeves, P. Meleady, M. Henry, O. J. McElvaney, T. P. Carroll, C. Condron, S. H. Chotirmall, M. Clynes, S. J. O'Neill, and N. G. McElvaney. 2010. a-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120: 4236-4250.
34. Tirouvanziam, R., Y. Gernez, C. K. Conrad, R. B. Moss, I. Schrijver, C. E. Dunn, Z. A. Davies, L. A. Herzenberg, and L. A. Herzenberg. 2008. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc. Natl. Acad. Sci. USA 105: 4335-4339.
35. Vega-Carrascal, I., E. P. Reeves, T. Niki, T. Arikawa, P. McNally, S. J. O'Neill, M. Hirashima, and N. G. McElvaney. 2011. Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J. Immunol. 186: 2897-2909.
36. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
37. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
38. Watt, A. P., J. Courtney, J. Moore, M. Ennis, and J. S. Elborn. 2005. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 60: 659-664.
39. Babior, B. M., R. S. Kipnes, and J. T. Curnutte. 1973. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52: 741-744.
40. Bergin, D. A., C. M. Greene, E. E. Sterchi, C. Kenna, P. Geraghty, A. Belaaouaj, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney. 2008. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. [Published erratum appears in 2009. J. Biol. Chem. 284: 9624.] J. Biol. Chem. 283: 31736-31744.
41. Weingart, C. L., G. Broitman-Maduro, G. Dean, S. Newman, M. Peppler, and A. A. Weiss. 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67: 4264-4267.
42. Gupta, S. K., S. Masinick, M. Garrett, and L. D. Hazlett. 1997. Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect. Immun. 65: 2747-2753.
43. Li, Y., M. Komai-Koma, D. S. Gilchrist, D. K. Hsu, F.-T. Liu, T. Springall, and D. Xu. 2008. Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J. Immunol. 181: 2781-2789.
44. Mey, A., H. Leffler, Z. Hmama, G. Normier, and J. P. Revillard. 1996. The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J. Immunol. 156: 1572-1577.
45. Janusonis, S. 2009. Comparing two small samples with an unstable, treatmentindependent baseline. J. Neurosci. Methods 179: 173-178.
46. Idali, F., J. Wahlström, B. Dahlberg, M. Khademi, T. Olsson, A. Eklund, and J. Grunewald. 2009. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir. Res. 10: 42.
47. van De Weyer, P. S., M. Muehlfeit, C. Klose, J. V. Bonventre, G. Walz, and E. W. Kuehn. 2006. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem. Biophys. Res. Commun. 351: 571-576.
48. Witko-Sarsat, V., R. C. Allen, M. Paulais, A. T. Nguyen, G. Bessou, G. Lenoir, and B. Descamps-Latscha. 1996. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J. Immunol. 157: 2728-2735.
49. Yamaoka, A., I. Kuwabara, L. G. Frigeri, and F. T. Liu. 1995. A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J. Immunol. 154: 3479-3487.
50. Kelher, M. R., D. R. Ambruso, D. J. Elzi, S. M. Anderson, A. J. Paterson, G. W. Thurman, and C. C. Silliman. 2003. Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils. Cell Calcium 34: 445-455.
51. Kashio, Y., K. Nakamura, M. J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, and M. Hirashima. 2003. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 170: 3631-3636.
52. Nagahara, K., T. Arikawa, S. Oomizu, K. Kontani, A. Nobumoto, H. Tateno, K. Watanabe, T. Niki, S. Katoh, M. Miyake, et al. 2008. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J. Immunol. 181: 7660-7669.
53. Zhao, J., Z. Lei, Y. Liu, B. Li, L. Zhang, H. Fang, C. Song, X. Wang, G. M. Zhang, Z. H. Feng, and B. Huang. 2009. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J. Immunol. 182: 6618-6624.
54. Chagan-Yasutan, H., H. Saitoh, Y. Ashino, T. Arikawa, M. Hirashima, S. Li, M. Usuzawa, S. Oguma, E. F. O Telan, C. L. Obi, and T. Hattori. 2009. Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J. Exp. Med. 218: 285-292.
55. Mengshol, J. A., L. Golden-Mason, T. Arikawa, M. Smith, T. Niki, R. McWilliams, J. A. Randall, R. McMahan, M. A. Zimmerman, M. Rangachari, et al. 2010. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5: e9504.
56. Pelletier, I., and S. Sato. 2002. Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope. J. Biol. Chem. 277: 17663-17670.
57. Fradin, C., D. Poulain, and T. Jouault. 2000. beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect. Immun. 68: 4391-4398.
58. Anderson, A. C., D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143.
59. Ju, Y., N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, et al. 2010. T cell immunoglobulin-And mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52: 322-329.
60. Nakayama, M., H. Akiba, K. Takeda, Y. Kojima, M. Hashiguchi, M. Azuma, H. Yagita, and K. Okumura. 2009. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113: 3821-3830.
61. Nakae, S., M. Iikura, H. Suto, H. Akiba, D. T. Umetsu, R. H. Dekruyff, H. Saito, and S. J. Galli. 2007. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110: 2565-2568.
62. Matsumoto, R., H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, and M. Hirashima. 1998. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273: 16976-16984.
63. Zhang, Y., C. J. Ma, J. M. Wang, X. J. Ji, X. Y. Wu, J. P. Moorman, and Z. Q. Yao. 2012. Tim-3 regulates pro-And anti-inflammatory cytokine expression in human CD14+ monocytes. J. Leukoc. Biol. 91: 189-196.
64. Sada-Ovalle, I., L. Chávez-Galán, L. Torre-Bouscoulet, L. Nava-Gamino, L. Barrera, P. Jayaraman, M. Torres-Rojas, M. A. Salazar-Lezama, and S. M. Behar. 2012. The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis. J. Immunol. 189: 5896-5902.
65. Painter, R. G., V. G. Valentine, N. A. Lanson, Jr., K. Leidal, Q. Zhang, G. Lombard, C. Thompson, A. Viswanathan, W. M. Nauseef, G. Wang, and G. Wang. 2006. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45: 10260-10269.
66. Sengelov, H., F. Boulay, L. Kjeldsen, and N. Borregaard. 1994. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucylphenylalanine in human neutrophils. Biochem. J. 299: 473-479.
67. Fortunati, E., K. M. Kazemier, J. C. Grutters, L. Koenderman, and J. Van den Bosch. 2009. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin. Exp. Immunol. 155: 559-566.
68. Ichimura, T., E. J. Asseldonk, B. D. Humphreys, L. Gunaratnam, J. S. Duffield, and J. V. Bonventre. 2008. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118: 1657-1668.
69. Almkvist, J., C. Dahlgren, H. Leffler, and A. Karlsson. 2002. Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. J. Immunol. 168: 4034-4041.
70. Karlsson, A., P. Follin, H. Leffler, and C. Dahlgren. 1998. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood 91: 3430-3438.
71. Farnworth, S. L., N. C. Henderson, A. C. Mackinnon, K. M. Atkinson, T. Wilkinson, K. Dhaliwal, K. Hayashi, A. J. Simpson, A. G. Rossi, C. Haslett, and T. Sethi. 2008. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am. J. Pathol. 172: 395-405.
72. Katoh, S., A. Nobumoto, N. Matsumoto, K. Matsumoto, N. Ehara, T. Niki, H. Inada, N. Nishi, A. Yamauchi, K. Fukushima, and M. Hirashima. 2010. Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int. Arch. Allergy Immunol. 153: 294-302.
73. Cystic Fibrosis Foundation Patient Registry. 2010. 2009 Annual Data Report to the Center of Directors. Cystic Fibrosis Foundation, Bethesda, MD.
74. Burns, J. L., R. L. Gibson, S. McNamara, D. Yim, J. Emerson, M. Rosenfeld, P. Hiatt, K. McCoy, R. Castile, A. L. Smith, and B. W. Ramsey. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183: 444-452.
75. Cramer, N., L. Wiehlmann, and B. Tümmler. 2010. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. Int. J. Med. Microbiol. 300: 526-533.
76. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60: 539-574.
77. Dakin, C. J., A. H. Numa, H. E. Wang, J. R. Morton, C. C. Vertzyas, and R. L. Henry. 2002. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165: 904-910.
78. Pittman, J. E., E. H. Calloway, M. Kiser, J. Yeatts, S. D. Davis, M. L. Drumm, M. S. Schechter, M.W. Leigh, M. Emond, A. Van Rie, and M. R. Knowles. 2011. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr. Pulmonol. 46: 497-504.
79. Hubbard, R. C., N. G. McElvaney, S. E. Sellers, J. T. Healy, D. B. Czerski, and R. G. Crystal. 1989. Recombinant DNA-produced alpha 1-Antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-Antitrypsin deficiency. J. Clin. Invest. 84: 1349-1354.
80. McElvaney, N. G., R. C. Hubbard, P. Birrer, M. S. Chernick, D. B. Caplan, M. M. Frank, and R. G. Crystal. 1991. Aerosol alpha 1-Antitrypsin treatment for cystic fibrosis. Lancet 337: 392-394.
81. Berger, M., R. U. Sorensen, M. F. Tosi, D. G. Dearborn, and G. Döring. 1989. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J. Clin. Invest. 84: 1302-1313.
82. Hartl, D., P. Latzin, P. Hordijk, V. Marcos, C. Rudolph, M.Woischnik, S. Krauss-Etschmann, B. Koller, D. Reinhardt, A. A. Roscher, et al. 2007. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat. Med. 13: 1423-1430.